News

iTeos Therapeutics Inc.: iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates
Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025 - Cash ...
Kura Oncology, Inc.: Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure - - Combination of ziftomenib and imatinib shows robust and dura ...